To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SNRNP25TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
227 supporting clones for gene SNRNP25 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG822464 adenocarcinoma cell line, colon .a 1 to 770 1 to 775       775/775
(100 %)
23 diff
(97.1 %id)
BG823343 adenocarcinoma cell line, colon .a 1 to 893 1 to 889   tiling clone,   889/889
(100 %)
17 diff
(98.1 %id)
BC001381 Colon, adenocarcinoma .a 2 to 1673 10 to 1682 exact available from MGC, AAA   1673/1673
(100 %)
2 diff
(99.9 %id)
BE304768 adenocarcinoma cell line, colon .a 21 to 662 1 to 640       640/702
(91 %)
11 diff
(98.5 %id)
CR613103 Placenta Cot 25-normalized .a 119 to 1637 1 to 1519 exact tiling clone,   1519/1519
(100 %)
0 diff
(100 %id)
AL544624 placenta, Placenta Cot 25-normalized .a 119 to 1222 1 to 1096       1096/1105
(99 %)
21 diff
(98.1 %id)
DA031577   .a 133 to 669 2 to 540   capped   539/539
(100 %)
7 diff
(98.8 %id)
AL528591 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 149 to 999 1 to 857   fully sequenced,   857/857
(100 %)
20 diff
(97.7 %id)
BU508290 leiomyosarcoma, uterus .a 152 to 938 1 to 790       790/978
(80 %)
21 diff
(97.9 %id)
BQ686053 ductal carcinoma, cell line, Pancreas .a 814 to 1673 1 to 864       864/975
(88 %)
14 diff
(98.6 %id)
NM_024571.3   .a 814 to 1898 1 to 1085   RefSeq, AAA   1085/1085
(100 %)
0 diff
(100 %id)
DB474791 hippocampus .a 826 to 1336 1 to 511       511/512
(99 %)
4 diff
(99.3 %id)
CB137383 Liver .a 826 to 1424 1 to 599       599/599
(100 %)
1 diff
(99.9 %id)
BI252475 hepatocellular carcinoma, cell line, Liver .a 828 to 1593 1 to 771       771/771
(100 %)
14 diff
(98.2 %id)
BM006127 hepatocellular carcinoma, cell line, Liver .a 828 to 1683 1 to 861       861/883
(97 %)
13 diff
(98.6 %id)
TI_59386083   .a 828 to 1683 102 to 962       861/883
(97 %)
13 diff
(98.6 %id)
CB139779 Liver .a 828 to 1348 1 to 521       521/521
(100 %)
1 diff
(99.9 %id)
DB491799 hypothalamus .a 830 to 1252 1 to 421       421/421
(100 %)
6 diff
(98.6 %id)
BU960195 mixed (pool of 40 RNAs) .a 833 to 1458 1 to 635       635/796
(79 %)
20 diff
(97.5 %id)
BQ649836 hepatocellular carcinoma, cell line, Liver .a 837 to 1683 1 to 850       850/941
(90 %)
23 diff
(97.6 %id)
BU596584 mixed (pool of 40 RNAs) .a 840 to 1533 1 to 712       712/846
(84 %)
36 diff
(95.8 %id)
BP198001 adrenal gland .a 841 to 1422 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
DT217895 brain .a 842 to 1376 1 to 535       535/535
(100 %)
2 diff
(99.7 %id)
BG705791 brain, hypothalamus .a 843 to 1565 1 to 724       724/724
(100 %)
7 diff
(99.1 %id)
BG715647 brain, hypothalamus .a 843 to 1537 1 to 696       696/696
(100 %)
11 diff
(98.5 %id)
BP198617 adrenal gland .a 845 to 1426 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AJ708079 heart .a 845 to 1377 1 to 533       533/533
(100 %)
1 diff
(99.9 %id)
AK026593   .a 845 to 1679 1 to 835   available from FLJ, AAA   835/835
(100 %)
2 diff
(99.8 %id)
DT218492 brain .a 845 to 1487 1 to 643       643/643
(100 %)
1 diff
(99.9 %id)
DT219612 brain .a 845 to 1490 1 to 646       646/646
(100 %)
2 diff
(99.7 %id)
BQ690019 ductal carcinoma, cell line, Pancreas .a 845 to 1689 1 to 848       848/874
(97 %)
24 diff
(97.3 %id)
BU846188 ovary, teratocarcinoma, cell line .a 845 to 1682 1 to 839       839/843
(99 %)
2 diff
(99.8 %id)
BP273192   .a 845 to 1413 1 to 569       569/569
(100 %)
5 diff
(99.2 %id)
BP274087   .a 845 to 1412 1 to 567       567/567
(100 %)
8 diff
(98.6 %id)
CB124719 Liver .a 845 to 1273 1 to 429       429/429
(100 %)
2 diff
(99.6 %id)
BG701288 brain, hippocampus .a 847 to 1632 1 to 787       787/787
(100 %)
5 diff
(99.4 %id)
BM172260 brain, hippocampus .a 847 to 1453 1 to 607       607/607
(100 %)
10 diff
(98.4 %id)
BU597705 mixed (pool of 40 RNAs) .a 847 to 1548 1 to 706       706/833
(84 %)
19 diff
(97.8 %id)
BM694166 eye, RPE and Choroid .a 848 to 1363 10 to 524       515/524
(98 %)
5 diff
(99.1 %id)
CR609842 Neuroblastoma Cot 50-normalized .a 849 to 1690 1 to 842       842/842
(100 %)
0 diff
(100 %id)
AL529517 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 849 to 1679 1 to 831   AAA   831/831
(100 %)
3 diff
(99.7 %id)
TI_44166587   .a 849 to 1690 80 to 920       841/930
(90 %)
30 diff
(96.8 %id)
DB481602 hippocampus .a 850 to 1318 1 to 469       469/475
(98 %)
4 diff
(99.2 %id)
BQ212498 melanotic melanoma, skin .a 850 to 1643 1 to 805       805/955
(84 %)
15 diff
(98.5 %id)
BM687735 eye, eye anterior segment .a 850 to 1078 7 to 234       228/234
(97 %)
6 diff
(97.5 %id)
BE740319 adenocarcinoma cell line, ovary .a 851 to 1626 1 to 772       772/773
(99 %)
13 diff
(98.4 %id)
BI546401 brain, hippocampus .a 853 to 1690 1 to 837       837/847
(98 %)
29 diff
(96.6 %id)
BM045131 carcinoma, cell line, Prostate .a 854 to 1601 1 to 749       749/749
(100 %)
2 diff
(99.8 %id)
BX280185 embryonal carcinoma, cell line, testis .a 855 to 1356 1 to 502       502/502
(100 %)
1 diff
(99.9 %id)
CA395026 eye, RPE/choroid .a 855 to 1377 1 to 523       523/523
(100 %)
2 diff
(99.7 %id)
BG394819 eye, retinoblastoma .a 855 to 1631 1 to 772       772/862
(89 %)
15 diff
(98.3 %id)
BG830768 epithelioid carcinoma cell line, Pancreas .a 855 to 1328 1 to 481       481/892
(53 %)
16 diff
(98.3 %id)
AA306317   .a 856 to 1170 1 to 316       316/316
(100 %)
2 diff
(99.4 %id)
BQ439281 embryonal carcinoma, cell line, testis .a 857 to 1683 1 to 828       828/886
(93 %)
8 diff
(99.1 %id)
BQ218381 epithelioid carcinoma, Pancreas .a 858 to 1661 1 to 822       822/906
(90 %)
32 diff
(96.5 %id)
BI196080 brain, neuroblastoma .a 859 to 1545 1 to 688       688/688
(100 %)
2 diff
(99.8 %id)
BU860599 adenocarcinoma, cell line, breast .a 860 to 1670 1 to 825       825/891
(92 %)
40 diff
(95.6 %id)
AA312905   .a 861 to 1369 1 to 509       509/509
(100 %)
1 diff
(99.9 %id)
DW446374 Liver .a 861 to 1060 18 to 217       200/217
(92 %)
6 diff
(97.3 %id)
TI_57188018   .a 862 to 1565 47 to 751       705/707
(99 %)
9 diff
(98.8 %id)
BU521371 leiomyosarcoma, uterus .a 863 to 1191 1 to 329       329/329
(100 %)
0 diff
(100 %id)
CN258558 embryonic stem cells, DMSO-treated H9 cellline .a 865 to 1556 1 to 696       696/696
(100 %)
5 diff
(99.3 %id)
BQ219944 epithelioid carcinoma, Pancreas .a 865 to 1680 1 to 822   AAA   822/822
(100 %)
13 diff
(98.5 %id)
AA311776   .a 866 to 1309 1 to 447       447/447
(100 %)
5 diff
(98.9 %id)
BM691420 eye, RPE and Choroid .a 866 to 1375 1 to 510       510/510
(100 %)
5 diff
(99.1 %id)
AV740952 cord Blood .a 867 to 1419 43 to 581       539/583
(92 %)
20 diff
(96.6 %id)
CB126572 Liver .a 867 to 1250 1 to 384       384/384
(100 %)
1 diff
(99.8 %id)
BP248183 Kidney .a 868 to 1450 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BE793915 lung, small cell carcinoma .a 868 to 1667 7 to 806       800/836
(95 %)
19 diff
(97.8 %id)
BG166061 hypernephroma, cell line, Kidney .a 868 to 1630 1 to 749       749/959
(78 %)
27 diff
(97.2 %id)
BU859262 ovary, teratocarcinoma, cell line .a 868 to 1528 1 to 666       666/838
(79 %)
8 diff
(99.1 %id)
EL947506 eyeball .a 869 to 1412 1 to 543       543/543
(100 %)
5 diff
(99.1 %id)
BU557042 ovary, teratocarcinoma, cell line .a 869 to 1548 1 to 677       677/837
(80 %)
18 diff
(97.9 %id)
BG821126 adenocarcinoma cell line, colon .a 870 to 1632 1 to 766       766/904
(84 %)
14 diff
(98.5 %id)
BG823249 adenocarcinoma cell line, colon .a 870 to 1224 1 to 355       355/705
(50 %)
1 diff
(99.9 %id)
EL952012 eyeball .a 871 to 1399 12 to 540       529/540
(97 %)
6 diff
(98.9 %id)
BM477983 lymph, lymphoma, cell line .a 871 to 1677 31 to 838   AAA   808/838
(96 %)
7 diff
(99.2 %id)
BC009179 Lung, small cell carcinoma .a 872 to 1679 10 to 817   available from MGC, AAA   808/808
(100 %)
2 diff
(99.8 %id)
TI_153952287   .a 873 to 1587 100 to 822       723/1103
(65 %)
24 diff
(97.9 %id)
CN258557 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 877 to 1622 1 to 746       746/746
(100 %)
7 diff
(99.1 %id)
BX470450   .a 877 to 1291 1 to 414       414/414
(100 %)
3 diff
(99.3 %id)
BQ057117 lymph, lymphoma, cell line .a 880 to 1683 27 to 836       810/934
(86 %)
25 diff
(97.4 %id)
BG024156 duodenal adenocarcinoma, cell line, small intestine .a 882 to 1679 1 to 800       800/1089
(73 %)
31 diff
(97.2 %id)
AA249742   .a 884 to 1130 1 to 237       237/242
(97 %)
16 diff
(93.4 %id)
BE910615 epithelioid carcinoma, Pancreas .a 889 to 1672 1 to 784   AAA   784/784
(100 %)
29 diff
(96.4 %id)
BE792311 lung, small cell carcinoma .a 890 to 1651 1 to 761       761/763
(99 %)
6 diff
(99.3 %id)
BU521007 leiomyosarcoma, uterus .a 891 to 1680 1 to 792   AAA   792/792
(100 %)
9 diff
(98.9 %id)
BE792717 lung, small cell carcinoma .a 892 to 1402 1 to 512       512/512
(100 %)
1 diff
(99.9 %id)
CD675862 eye, lens .a 897 to 1524 1 to 628       628/628
(100 %)
2 diff
(99.7 %id)
Z84714   .a 901 to 1673 1 to 774   AAA   774/774
(100 %)
2 diff
(99.8 %id)
TI_149310554   .a 902 to 1685 867 to 85   AAA   783/958
(81 %)
10 diff
(99.0 %id)
EL945727 eyeball .a 903 to 1134 1 to 242       238/243
(97 %)
12 diff
(95.1 %id)
BF091854 testis_normal .a 906 to 1134 1 to 229       229/306
(74 %)
2 diff
(99.4 %id)
CA426773 cell lines, Chondrosarcoma .a 930 to 1679 769 to 19   AAA   751/751
(100 %)
3 diff
(99.7 %id)
AV749249 Pituitary .a 937 to 1054 1 to 118       118/121
(97 %)
2 diff
(98.4 %id)
BQ222254 epithelioid carcinoma, Pancreas .a 939 to 1679 1 to 742       742/746
(99 %)
5 diff
(99.4 %id)
CN258556 embryonic stem cells, DMSO-treated H9 cellline .a 941 to 1346 1 to 406       406/406
(100 %)
0 diff
(100 %id)
BM794653 Ascites, stomach .a 941 to 1594 1 to 654       654/654
(100 %)
0 diff
(100 %id)
BG489760 large cell carcinoma, lung .a 942 to 1543 1 to 602       602/602
(100 %)
4 diff
(99.4 %id)
BE396847 Burkitt lymphoma, lymph .a 944 to 1481 1 to 541       541/541
(100 %)
4 diff
(99.3 %id)
BM793747 Ascites, stomach .a 945 to 1427 1 to 484       484/484
(100 %)
5 diff
(99.0 %id)
BG389418 embryonal carcinoma, cell line, testis .a 951 to 1466 1 to 532       500/557
(89 %)
12 diff
(97.9 %id)
TI_154052781   .a 952 to 1673 794 to 82   AAA   713/908
(78 %)
26 diff
(97.2 %id)
BU688840 lung .a 952 to 1685 752 to 19   AAA   734/734
(100 %)
6 diff
(99.2 %id)
CR620069 HeLa cells Cot 25-normalized .a 956 to 1690 1 to 735       735/735
(100 %)
0 diff
(100 %id)
AL555300 placenta .a 956 to 1679 1 to 724   fully sequenced, AAA   724/724
(100 %)
2 diff
(99.8 %id)
AL528590 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 969 to 1659 688 to 1   fully sequenced,   688/688
(100 %)
10 diff
(98.6 %id)
BF951691 nervous_normal .a 971 to 1547 11 to 585       575/585
(98 %)
8 diff
(98.7 %id)
CV028198 mixed .a 975 to 1372 1 to 398       398/567
(70 %)
2 diff
(99.7 %id)
BF109974 pooled .a 984 to 1670 698 to 12       687/698
(98 %)
4 diff
(99.5 %id)
FN156357 breast carcinoma .a 985 to 1043 1 to 59       59/65
(90 %)
3 diff
(95.4 %id)
BF732786 fibrotheoma, ovary .a 997 to 1673 676 to 1       676/680
(99 %)
13 diff
(98.1 %id)
FN161467 breast carcinoma .a 1004 to 1077 1 to 74       74/74
(100 %)
1 diff
(98.7 %id)
BQ881338 brain, neuroblastoma, cell line .a 1009 to 1594 1 to 595       595/849
(70 %)
14 diff
(98.4 %id)
AL555299 placenta .a 1013 to 1643 632 to 1   fully sequenced,   632/632
(100 %)
12 diff
(98.2 %id)
BM823854 Ascites, stomach .a 1013 to 1522 1 to 510       510/510
(100 %)
1 diff
(99.9 %id)
CA421642 Bone, Enchondroma cell line .a 1036 to 1679 662 to 19   AAA   644/644
(100 %)
1 diff
(99.9 %id)
W70134 heart .a 1048 to 1418 1 to 373   fully sequenced,   373/373
(100 %)
2 diff
(99.5 %id)
CR594984 Neuroblastoma Cot 25-normalized .a 1060 to 1886 1 to 827       827/827
(100 %)
0 diff
(100 %id)
BX353552 Neuroblastoma Cot 25-normalized .a 1060 to 1890 1 to 831   fully sequenced,   831/831
(100 %)
4 diff
(99.6 %id)
CA749008 cell lines, Chondrosarcoma .a 1068 to 1679 630 to 19   AAA   612/612
(100 %)
2 diff
(99.7 %id)
CA310457 cell lines, Chondrosarcoma .a 1081 to 1561 732 to 252   AAA   481/714
(67 %)
0 diff
(100 %id)
BP425572 small intestine .a 1097 to 1282 1 to 186     Submitted on the opposite strand 186/186
(100 %)
1 diff
(99.5 %id)
FN170392 breast carcinoma .a 1098 to 1181 1 to 84       84/84
(100 %)
4 diff
(95.3 %id)
BF109957 pooled .a 1106 to 1679 576 to 1       576/578
(99 %)
10 diff
(98.3 %id)
BM789068 Ascites, stomach .a 1111 to 1435 1 to 325       325/328
(99 %)
2 diff
(99.4 %id)
BM712091 eye, lens .a 1123 to 1293 1 to 171   fully sequenced,   171/171
(100 %)
0 diff
(100 %id)
BQ932373 leiomyosarcoma, uterus .a 1135 to 1674 1 to 541       541/1190
(45 %)
5 diff
(99.6 %id)
AW007372 anaplastic oligodendroglioma, brain .a 1170 to 1674 506 to 2       505/506
(99 %)
0 diff
(100 %id)
AI806356 pooled .a 1171 to 1674 506 to 3       504/506
(99 %)
0 diff
(100 %id)
BG771360 adenocarcinoma, Prostate .a 1178 to 1683 12 to 517   AAA   506/517
(97 %)
8 diff
(98.5 %id)
BM662380 eye, RPE and Choroid .a 1180 to 1673 511 to 18   AAA   494/494
(100 %)
1 diff
(99.8 %id)
CA426905 cell lines, Chondrosarcoma .a 1181 to 1561 632 to 252   AAA   381/614
(62 %)
0 diff
(100 %id)
DB576347 hypothalamus .a 1194 to 1679 1 to 486     Submitted on the opposite strand 486/486
(100 %)
2 diff
(99.6 %id)
BE548959 cervical carcinoma cell line, cervix .a 1199 to 1681 1 to 487       487/487
(100 %)
16 diff
(96.8 %id)
AI310876 brain, oligodendroglioma .a 1207 to 1615 5 to 412     Submitted on the opposite strand 408/412
(99 %)
8 diff
(98.1 %id)
AI311983 brain, oligodendroglioma .a 1207 to 1564 5 to 361     Submitted on the opposite strand 357/361
(98 %)
8 diff
(97.8 %id)
AI318144 early stage papillary serous carcinoma, ovary .a 1207 to 1602 16 to 411     Submitted on the opposite strand 396/411
(96 %)
6 diff
(98.6 %id)
AI318564 early stage papillary serous carcinoma, ovary .a 1207 to 1600 16 to 409     Submitted on the opposite strand 394/409
(96 %)
6 diff
(98.6 %id)
AI583767 bone marrow, CD34+, T negative, patient with chronicmyelogenous leukemia .a 1207 to 1635 6 to 434     Submitted on the opposite strand 429/434
(98 %)
7 diff
(98.4 %id)
AI609908 brain, oligodendroglioma .a 1207 to 1635 28 to 456     Submitted on the opposite strand 429/456
(94 %)
5 diff
(99.0 %id)
AW073622 bone marrow, stem cell 34+/38+ .a 1207 to 1635 5 to 434     Submitted on the opposite strand 430/434
(99 %)
7 diff
(98.4 %id)
AW072898 bone marrow, stem cell 34+/38+ .a 1207 to 1652 5 to 451     Submitted on the opposite strand 447/451
(99 %)
13 diff
(97.2 %id)
BF054752 brain, oligodendroglioma .a 1207 to 1682 34 to 509       476/509
(93 %)
7 diff
(98.7 %id)
BF055800 brain, oligodendroglioma .a 1207 to 1637 34 to 464       431/464
(92 %)
6 diff
(98.8 %id)
DB543626 hippocampus .a 1216 to 1679 1 to 464     Submitted on the opposite strand 464/464
(100 %)
2 diff
(99.6 %id)
BG941944 blood .a 1221 to 1553 1 to 333       333/333
(100 %)
9 diff
(97.3 %id)
BF054666 brain, oligodendroglioma .a 1221 to 1669 1 to 449       449/449
(100 %)
1 diff
(99.8 %id)
AW949475   .a 1222 to 1673 1 to 452   AAA   452/452
(100 %)
1 diff
(99.8 %id)
AW949482   .a 1222 to 1673 1 to 452   AAA   452/452
(100 %)
9 diff
(98.1 %id)
T83419 liver and spleen .a 1223 to 1548 1 to 332       332/375
(88 %)
7 diff
(98.2 %id)
AA335786 epididymis .a 1228 to 1481 1 to 254       254/254
(100 %)
0 diff
(100 %id)
AA335793 epididymis .a 1228 to 1504 1 to 280       280/286
(97 %)
8 diff
(97.3 %id)
AA873067 pooled germ cell tumors .a 1229 to 1679 451 to 1       451/451
(100 %)
1 diff
(99.8 %id)
BM670381 eye, lens .a 1263 to 1679 435 to 19   fully sequenced, AAA   417/417
(100 %)
2 diff
(99.6 %id)
F34873 pectoral muscle (after mastectomy) .a 1312 to 1647 1 to 336       336/336
(100 %)
5 diff
(98.6 %id)
BQ355777 head_neck .a 1316 to 1729 35 to 447       413/456
(90 %)
4 diff
(99.2 %id)
AI278216 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1316 to 1685 370 to 1       370/372
(99 %)
2 diff
(99.5 %id)
F28363 pectoral muscle (after mastectomy) .a 1321 to 1679 1 to 359   AAA   359/359
(100 %)
1 diff
(99.8 %id)
BF836722 head_neck .a 1325 to 1566 246 to 1     Submitted on the opposite strand 246/246
(100 %)
7 diff
(97.2 %id)
F36768 pectoral muscle (after mastectomy) .a 1335 to 1683 1 to 349       349/352
(99 %)
2 diff
(99.5 %id)
BU608952 Human Lung Epithelial cells, lung .a 1336 to 1673 357 to 19   AAA   339/342
(99 %)
5 diff
(98.6 %id)
AJ345974 pectoral muscle (after mastectomy) .a 1349 to 1672 1 to 324   AAA   324/324
(100 %)
1 diff
(99.7 %id)
AI095295 senescent fibroblast .a 1350 to 1674 328 to 5       324/328
(98 %)
0 diff
(100 %id)
F26889 pectoral muscle (after mastectomy) .a 1354 to 1679 1 to 326   AAA   326/326
(100 %)
1 diff
(99.7 %id)
AW024758 Kidney .a 1358 to 1679 322 to 1       322/322
(100 %)
1 diff
(99.7 %id)
BX390222 Neuroblastoma Cot 50-normalized .a 1360 to 1679 32 to 348   AAA   317/348
(91 %)
6 diff
(98.3 %id)
BP394128 pancreatic islet .a 1360 to 1669 1 to 310     Submitted on the opposite strand 310/457
(67 %)
2 diff
(99.6 %id)
BU601504 mixed (pool of 40 RNAs) .a 1370 to 1679 1 to 310   AAA   310/310
(100 %)
2 diff
(99.4 %id)
F29373 pectoral muscle (after mastectomy) .a 1373 to 1686 1 to 314       314/316
(99 %)
3 diff
(99.1 %id)
AA327538 colon .a 1378 to 1673 1 to 296       296/296
(100 %)
4 diff
(98.7 %id)
AW952306   .a 1379 to 1673 1 to 295   AAA   295/295
(100 %)
4 diff
(98.7 %id)
BF974559 B-cells, primary B-cells from tonsils (cell line) .a 1380 to 1690 1 to 313       313/323
(96 %)
7 diff
(97.9 %id)
W70143 heart .a 1388 to 1679 293 to 1   fully sequenced,   293/293
(100 %)
1 diff
(99.7 %id)
BM453139 leiomyosarcoma, uterus .a 1390 to 1673 13 to 296   AAA   284/296
(95 %)
6 diff
(98.0 %id)
BX372673 Neuroblastoma Cot 25-normalized .a 1394 to 1886 494 to 1   fully sequenced,   494/494
(100 %)
17 diff
(96.6 %id)
FN080062 breast carcinoma .a 1408 to 1482 79 to 4     Submitted on the opposite strand 76/79
(96 %)
0 diff
(100 %id)
AA225166   .a 1416 to 1898 503 to 11   AAA   493/496
(99 %)
23 diff
(95.4 %id)
AI345042 invasive adenocarcinoma, lung .a 1426 to 1558 1 to 133     Submitted on the opposite strand 133/133
(100 %)
1 diff
(99.3 %id)
BF769206 epid_tumor .a 1445 to 1614 12 to 176       165/182
(90 %)
8 diff
(95.7 %id)
AA954516 Kidney .a 1449 to 1675 227 to 1       227/227
(100 %)
1 diff
(99.6 %id)
DB550415 hippocampus .a 1451 to 1916 1 to 466   tiling clone, Submitted on the opposite strand 466/466
(100 %)
4 diff
(99.2 %id)
BF769200 epid_tumor .a 1453 to 1614 18 to 176       159/182
(87 %)
7 diff
(96.2 %id)
BM052945 Islets of Langerhans, Pancreas .a 1457 to 1679 1 to 223   AAA   223/223
(100 %)
1 diff
(99.6 %id)
BM052907 Islets of Langerhans, Pancreas .a 1457 to 1679 1 to 223   AAA   223/223
(100 %)
1 diff
(99.6 %id)
BM052988 Islets of Langerhans, Pancreas .a 1457 to 1679 1 to 223   AAA   223/223
(100 %)
1 diff
(99.6 %id)
AI802373   .a 1464 to 1673 224 to 15   AAA   210/210
(100 %)
1 diff
(99.6 %id)
AI567459 anaplastic oligodendroglioma, brain .a 1464 to 1678 247 to 33   AAA   215/215
(100 %)
4 diff
(98.2 %id)
AA613023 colon, colon tumor RER+ .a 1495 to 1674 180 to 1       180/180
(100 %)
1 diff
(99.5 %id)
AA888591 carcinoid, lung .a 1495 to 1678 184 to 1       184/184
(100 %)
1 diff
(99.5 %id)
FN139396 breast carcinoma .a 1500 to 1606 1 to 107       107/107
(100 %)
1 diff
(99.1 %id)
AI620900 Prostate .a 1506 to 1679 174 to 1       174/175
(99 %)
0 diff
(100 %id)
EC488167 Prostate .a 1507 to 1608 1 to 103       103/103
(100 %)
2 diff
(98.1 %id)
EC471082 Prostate .a 1508 to 1610 1 to 101       101/103
(98 %)
3 diff
(97.1 %id)
EC569327 Prostate .a 1508 to 1608 1 to 99       99/99
(100 %)
2 diff
(98.0 %id)
EC546717 Prostate .a 1510 to 1608 1 to 99       99/99
(100 %)
0 diff
(100 %id)
EC444397 Prostate .a 1513 to 1608 1 to 95       95/95
(100 %)
1 diff
(99.0 %id)
AI820975   .a 1530 to 1898 387 to 19   tiling clone, AAA   369/369
(100 %)
0 diff
(100 %id)
BX395439 Neuroblastoma Cot 50-normalized .b -9 to 921 1 to 830   tiling clone, AAA   765/830
(92 %)
68 diff
(91.9 %id)
BU170293 eye, retinoblastoma .b 14 to 805 1 to 797   tiling clone,   797/849
(93 %)
15 diff
(98.3 %id)
BX097549 breast .c 1 to 740 1 to 739   tiling clone,   739/739
(100 %)
1 diff
(99.9 %id)
T83528 liver and spleen .c 223 to 522 1 to 311       311/355
(87 %)
13 diff
(96.4 %id)
AW384801 head_neck .c 373 to 977 609 to 8       602/611
(98 %)
4 diff
(99.4 %id)
CA313724 Human Lung Epithelial cells, lung .c 554 to 1249 713 to 19 exact tiling clone, AAA   695/695
(100 %)
2 diff
(99.8 %id)
CA313733 Human Lung Epithelial cells, lung .c 676 to 1249 594 to 20 P14H L26M L29V R30S V31C ... AAA   575/575
(100 %)
14 diff
(97.6 %id)
AA833790 germinal center B cell .c 795 to 1255 472 to 13   AAA   460/460
(100 %)
1 diff
(99.8 %id)
R55515 breast .c 805 to 1254 458 to 1   tiling clone,   458/463
(98 %)
12 diff
(97.5 %id)
AI361687 anaplastic oligodendroglioma, brain .c 822 to 1255 432 to 1       432/432
(100 %)
2 diff
(99.6 %id)
BF965808 Bone, osteosarcoma, cell line .c 823 to 1235 1 to 413       413/913
(45 %)
4 diff
(99.6 %id)
DB562611 hypothalamus .c 826 to 1255 1 to 430     Submitted on the opposite strand 430/430
(100 %)
1 diff
(99.8 %id)
AA825409 carcinoid, lung .c 832 to 1258 425 to 1       425/425
(100 %)
4 diff
(99.1 %id)
AA961649 Kidney, kidney tumor .c 833 to 1214 382 to 1       382/382
(100 %)
2 diff
(99.5 %id)
BF030156 hypernephroma, Kidney .c 836 to 1276 1 to 441   tiling clone,   441/455
(96 %)
3 diff
(99.4 %id)
AJ346502 pectoral muscle (after mastectomy) .c 838 to 1237 1 to 400       400/400
(100 %)
1 diff
(99.8 %id)
AA580460 colon, colon tumor .c 838 to 1249 412 to 1       412/412
(100 %)
2 diff
(99.6 %id)
AI742126 pooled .c 839 to 1249 424 to 15   AAA   410/410
(100 %)
3 diff
(99.3 %id)
AI393539 pooled .c 843 to 1254 412 to 1       412/412
(100 %)
2 diff
(99.6 %id)
AA836027 germinal center B cell .c 850 to 1259 415 to 6       410/415
(98 %)
0 diff
(100 %id)
BE676385 B-cell, chronic lymphotic leukemia .c 852 to 1250 399 to 1       399/399
(100 %)
1 diff
(99.8 %id)
AA299789 uterus .c 873 to 1259 392 to 5       388/392
(98 %)
0 diff
(100 %id)
AI564393 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 874 to 1250 379 to 6       374/379
(98 %)
0 diff
(100 %id)
T83383 liver and spleen .c 919 to 1257 342 to 1       342/397
(86 %)
14 diff
(96.5 %id)
BF981278 duodenal adenocarcinoma, cell line, small intestine .d-u 124 to 759 1 to 635   tiling clone,   635/636
(99 %)
6 diff
(99.1 %id)
AF289572   .e 1 to 1137 181 to 1317 exact tiling clone, AAA   1137/1317
(86 %)
7 diff
(99.5 %id)
AF289607   .e 1 to 1137 181 to 1317 exact tiling clone, AAA   1137/1317
(86 %)
7 diff
(99.5 %id)
AA299788 uterus .e 138 to 482 1 to 345       345/347
(99 %)
3 diff
(99.2 %id)
DA429765 colon .f-u 1 to 568 2 to 569 exact tiling clone, capped   568/568
(100 %)
1 diff
(99.9 %id)
DB252599 uterus .f-u 3 to 477 2 to 476 G46* tiling clone, capped   475/475
(100 %)
2 diff
(99.6 %id)
DB088492 testis .f-u 16 to 560 2 to 546 exact capped   545/545
(100 %)
1 diff
(99.9 %id)
DA537445 Kidney .f-u 25 to 556 2 to 533 exact capped   532/532
(100 %)
1 diff
(99.9 %id)
CR590942 Neuroblastoma Cot 50-normalized Gene SNRNP25, variant not shown         This clone was ignored    
BM549610 leukocyte Gene SNRNP25, variant not shown              
BP346673 brain Gene SNRNP25, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u, .e, .f-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI